JP
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Multi-omics correlates of insulin resistance and circadian parameters mapped directly from human serum | European journal of neuroscience |  | 2024 | 86 | 205 | ||
| Circadian organization of lipid landscape is perturbed in type 2 diabetic patients | Cell reports medicine | | 2023 | 274 | 153 | ||
| The impact of transsphenoidal surgery on pituitary function in patients with non-functioning macroadenomas | Endocrine | | 2023 | 147 | 350 | ||
| Moderate to Severe Soft Tissue Diabetic Foot Infections: A Randomized, Controlled, Pilot Trial of Post-debridement Antibiotic Treatment for 10 versus 20 days | Annals of surgery | | 2022 | 262 | 403 | ||
| Growth differentiation factor-15 prevents glucotoxicity and connexin-36 downregulation in pancreatic beta-cells | Molecular and cellular endocrinology | | 2022 | 107 | 194 | ||
| Ether lipids, sphingolipids and toxic 1-deoxyceramides as hallmarks for lean and obese type 2 diabetic patients | Acta Physiologica |  | 2021 | 401 | 3 | ||
| Sphingosine‐1‐phosphate as a key player of insulin secretion induced by high‐density lipoprotein treatment | Physiological reports | | 2021 | 260 | 181 | ||
| Three versus six weeks of antibiotic therapy for diabetic foot osteomyelitis: A prospective, randomized, non-inferiority pilot trial | Clinical Infectious Diseases | | 2020 | 347 | 1,091 | ||
| Analogues du GLP-1 en 2019 : pour qui et comment ? | Revue médicale suisse | | 2019 | 464 | 1 | ||
| Faut-il prescrire plus d'inhibiteurs SGLT-2 ? | Revue médicale suisse | | 2019 | 309 | 170 | ||
| Cellular circadian period length inversely correlates with HbA1c levels in individuals with type 2 diabetes | Diabetologia | | 2019 | 524 | 5 | ||
| High-fat diet impacts more changes in beta-cell compared to alpha-cell transcriptome | PloS one | | 2019 | 5 | 33 | ||
| Association between polycystic ovary syndrome and venous thromboembolism: A systematic review and meta-analysis | Thrombosis Research | | 2019 | 357 | 1 | ||
| Validation of molecular biomarkers for preoperative diagnostics of human papillary thyroid carcinoma in fine needle aspirates | Gland Surgery | | 2019 | 504 | 5 | ||
| Observance thérapeutique et empilage médicamenteux | Revue médicale suisse | | 2018 | 372 | 213 | ||
| Composite pheochromocytoma with neuroblastoma: a case report | 20th European Congress of Endocrinology | 2018 | 159 | 1 | |||
| Time zones of pancreatic islet metabolism | Diabetes, Obesity and Metabolism | | 2018 | 474 | 0 | ||
| Identification of Differential Transcriptional Patterns in Primary and Secondary Hyperparathyroidism | Journal of Clinical Endocrinology and Metabolism | | 2018 | 668 | 4 | ||
| Consequences of the Adoption of the IADPSG versus Carpenter and Coustan Criteria to Diagnose Gestational Diabetes: A Before-After Comparison | Experimental and Clinical Endocrinology and Diabetes | | 2018 | 517 | 2 | ||
| Manifestations musculosquelettiques du diabète sucré : une complication fréquente | Revue médicale suisse | | 2017 | 372 | 0 | ||
| Anti-CTLA-4 Monoclonal Antibodies Induced Hypophysitis: Case Report and Literature Review | Annals of Clinical Case Reports | | 2017 | 455 | 143 | ||
| Traitement du diabète de type 2 : risques et bénéfices de la chirurgie métabolique | Revue médicale suisse | | 2017 | 379 | 0 | ||
| Traitement du diabète: quand faire appel au diabétologue? | Revue médicale suisse | | 2017 | 376 | 232 | ||
| Association des analogues du GLP-1 et des inhibiteurs du SGLT2 : de nouvelles perspectives ? | Revue médicale suisse | | 2017 | 392 | 0 | ||
| The search for preoperative biomarkers for thyroid carcinoma: application of the thyroid circadian clock properties | Biomarkers in medicine | | 2017 | 573 | 1 | ||
| Pancreatic α- and β-cellular clocks have distinct molecular properties and impact on islet hormone secretion and gene expression | Genes and Development | | 2017 | 640 | 62 | ||
| Optimization and testing of dried antibody tube: The EuroFlow LST and PIDOT tubes as examples | Journal of Immunological Methods | | 2017 | 402 | 1 | ||
| Prévention et guérison du diabète : est-ce possible ? | Revue médicale suisse | | 2016 | 466 | 0 | ||
| Identification of CHEK1, SLC26A4, c-KIT, TPO and TG as new biomarkers for human follicular thyroid carcinoma | Oncotarget | | 2016 | 678 | 284 | ||
| Functional and Molecular Adaptations of Enteroendocrine L-Cells in Male Obese Mice Are Associated With Preservation of Pancreatic α-Cell Function and Prevention of Hyperglycemia | Endocrinology | | 2016 | 537 | 0 | ||
| Effects of liver transplantation on endocrine function: a systematic review | Liver international | | 2016 | 557 | 4 | ||
| α-Cell Dysfunctions and Molecular Alterations in Male Insulinopenic Diabetic Mice Are Not Completely Corrected by Insulin | Endocrinology | | 2016 | 618 | 1 | ||
| Comment faire pour prévenir le diabète de type 2 en Suisse? | Revue médicale suisse | | 2016 | 424 | 2 | ||
| Dysthyroïdies liées à une surcharge iodée | Revue médicale suisse | | 2016 | 400 | 0 | ||
| Insuline et antidiabétiques oraux : comment les associer dans la pratique ambulatoire ? | Revue médicale suisse | | 2016 | 511 | 3 | ||
| Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway | Proceedings of the National Academy of Sciences of the United States of America | | 2015 | 567 | 339 | ||
| Thyroid Circadian Timing: Roles in Physiology and Thyroid Malignancies | Journal of biological rhythms | | 2015 | 695 | 0 | ||
| Free Fatty Acids Impair FGF21 Action in HepG2 Cells | Cellular physiology and biochemistry | | 2015 | 563 | 579 | ||
| Endogenous endophthalmitis in a patient with diabetes and foot osteomyelitis | Canadian journal of diabetes | | 2015 | 548 | 0 | ||
| Acute painful diabetic neuropathy: an uncommon, remittent type of acute distal small fibre neuropathy | Schweizerische medizinische Wochenschrift | | 2015 | 600 | 2 | ||
| Erreurs innées du métabolisme: transition enfant-adulte | Revue médicale suisse | | 2015 | 620 | 2 | ||
| Statins and Diabetes: The Plot Thickens | Journal of general internal medicine | | 2015 | 460 | 0 | ||
| Le diabète en 2015 : en augmentation constante, mais avec une offre thérapeutique qui s'élargit | Revue médicale suisse | | 2015 | 408 | 1 | ||
| Baisse de la déhydroépiandrostérone avec l'âge : pertinence clinique et intérêt thérapeutique | Revue médicale suisse | | 2015 | 571 | 1 | ||
| Restoration of adrenal function after bilateral adrenal damage due to heparin-induced thrombocytopenia (HIT): a case report | Journal of medical case reports | | 2015 | 681 | 341 | ||
| Endocrinologie :l'hyperparathyroïdie primaire asymptomatique en 2014 | Revue médicale suisse | | 2015 | 509 | 1 | ||
| Identification of new biomarkers for human papillary thyroid carcinoma employing NanoString analysis | Oncotarget | | 2015 | 784 | 445 | ||
| Diabétologie | Revue médicale suisse | | 2015 | 495 | 0 | ||
| Analogues du GLP-1 versus inhibiteurs du SGLT-2 pour les diabétiques de type 2 obèses | Revue médicale suisse | | 2015 | 506 | 1 | ||
| Syndrome des ovaires polykystiques : quoi de neuf ? | Revue médicale suisse | | 2015 | 560 | 1 | ||
| Endocrinologie | Revue médicale suisse | 2014 | 556 | 0 | |||
| Maladies hépatiques chroniques et diabète | Revue médicale suisse | | 2014 | 493 | 0 | ||
| Le concept de parcours de santé ou la difficile révolution de la prise en charge des maladies chroniques | Revue médicale suisse | | 2014 | 478 | 0 | ||
| Foxa1 and Foxa2 regulate α-cell differentiation, glucagon biosynthesis, and secretion | Endocrinology | | 2014 | 634 | 0 | ||
| La testostérone : un traitement pour la prévention des maladies cardiovasculaires ? | Revue médicale suisse | | 2014 | 512 | 0 | ||
| Traitement combiné d'insuline et d'analogue du GLP-1 : qu'en attendre ? | Revue médicale suisse | | 2014 | 578 | 0 | ||
| Quelle insuline pour quel patient en 2014 ? | Revue médicale suisse | | 2014 | 462 | 0 | ||
| Glucagon: the renewal of an old hormone in the pathophysiology of diabetes | Journal of diabetes and its complications | | 2013 | 596 | 0 | ||
| Autonomous and self-sustained circadian oscillators displayed in human islet cells | Diabetologia | | 2013 | 759 | 213 | ||
| Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside | Diabetes & metabolism | | 2013 | 647 | 0 | ||
| Circadian clock characteristics are altered in human thyroid malignant nodules | The Journal of clinical endocrinology and metabolism | | 2013 | 762 | 2 | ||
| A review of age-related dehydroepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial? | Rejuvenation research | | 2013 | 775 | 1,052 | ||
| Implications of somatostatin analogues in the treatment of acromegaly | European endocrinology | | 2013 | 371 | 240 | ||
| Hypoglycémie non diabétique : diagnostic et prise en charge | Revue médicale suisse | | 2013 | 685 | 2 | ||
| Sport et diabète de type 1 | Revue médicale suisse | 2013 | 680 | 0 | |||
| Biofeedback can reduce foot pressure to a safe level and without causing new at-risk zones in patients with diabetes and peripheral neuropathy | Diabetes/metabolism research and reviews | | 2013 | 621 | 1 | ||
| Maladies chroniques : le politique doit s'engager ! | Revue médicale suisse | | 2013 | 434 | 1 | ||
| Diabète de la personne âgée : une prise en charge sur mesure | Revue médicale suisse | | 2013 | 583 | 0 | ||
| Biological rhythms and preeclampsia | Frontiers in endocrinology | | 2013 | 757 | 572 | ||
| Pax6 is a key component of regulated glucagon secretion | Endocrinology | | 2012 | 1,061 | 0 | ||
| Sommeil et diabète | Revue médicale suisse | | 2012 | 515 | 0 | ||
| Diabète et stéatose hépatique non alcoolique | Revue médicale suisse | | 2012 | 636 | 0 | ||
| Néphropathie diabétique | Revue médicale suisse | | 2012 | 664 | 1 | ||
| Hypothermia is a frequent sign of severe hypoglycaemia in patients with diabetes | Diabetes & metabolism | | 2012 | 649 | 0 | ||
| Antidiabetic drugs and kidney disease--recommendations of the Swiss Society for Endocrinology and Diabetology | Schweizerische medizinische Wochenschrift | | 2012 | 2,026 | 1,389 | ||
| La médecine personnalisée et la face cachée de la lune | Revue médicale suisse | | 2012 | 500 | 1 | ||
| Pax6 is crucial for β-cell function, insulin biosynthesis, and glucose-induced insulin secretion | Molecular endocrinology | | 2012 | 663 | 0 | ||
| Glucagon gene expression in the endocrine pancreas: the role of the transcription factor Pax6 in α-cell differentiation, glucagon biosynthesis and secretion | Diabetes, obesity & metabolism | | 2011 | 654 | 0 | ||
| Glucagon responses of isolated α cells to glucose, insulin, somatostatin, and leptin | Endocrine practice | 2011 | 599 | 0 | |||
| Hémoglobine glyquée: nouvel outil de dépistage? | Revue médicale suisse | | 2011 | 719 | 1 | ||
| Prise en charge du diabète gestationnel: nouvelles connaissances et perspectives futures | Revue médicale suisse | | 2011 | 706 | 1 | ||
| Prise en charge du diabète et réseaux médicaux: est-ce la solution? | Revue médicale suisse | | 2011 | 508 | 0 | ||
| Diagnostic et traitement de l'insuffisance pancréatique exocrine lors d'un diabète | Diabetes, Stoffwechsel und Herz | 2011 | 553 | 0 | |||
| Importance de la décharge dans le traitement des lésions du pied diabétique | Revue médicale suisse | | 2011 | 563 | 1 | ||
| Multislice gated-computed tomography of cardiac paragangliomas | Journal of the American College of Cardiology | | 2010 | 508 | 0 | ||
| Pax6 controls the expression of critical genes involved in pancreatic {alpha} cell differentiation and function | The Journal of biological chemistry | | 2010 | 622 | 1 | ||
| Comment minimiser la prise de poids secondaire au traitement d'insuline? | Revue médicale suisse | 2010 | 642 | 0 | |||
| L'aspirine en prévention primaire chez les patients diabétiques | Revue médicale suisse | 2010 | 495 | 0 | |||
| Insuline et cancer: mythe ou realité? | Revue médicale suisse | 2010 | 598 | 0 | |||
| Diabète et cancer: une association pernicieuse | Revue médicale suisse | 2010 | 665 | 0 | |||
| Treating type 2 diabetes: how safe are current therapeutic agents? | International journal of clinical practice | | 2009 | 552 | 0 | ||
| Pax6 regulates the proglucagon processing enzyme PC2 and its chaperone 7B2 | Molecular and cellular biology | | 2009 | 643 | 0 | ||
| Long-term insulin-independence after allogeneic islet transplantation for type 1 diabetes: over the 10-year mark | American journal of transplantation | | 2009 | 982 | 6 | ||
| Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial | Diabetes, obesity & metabolism | | 2008 | 888 | 8 | ||
| Mucocutaneous papillomatous papules in Cowden's syndrome | Clinical and experimental dermatology | | 2008 | 559 | 0 | ||
| Motesanib diphosphate in progressive differentiated thyroid cancer | The New England journal of medicine | | 2008 | 556 | 0 | ||
| Sequential kidney/islet transplantation: efficacy and safety assessment of a steroid-free immunosuppression protocol | American journal of transplantation | | 2006 | 913 | 351 | ||
| Detection of insulin mRNA in the peripheral blood after human islet transplantion predicts deterioration of metabolic control | American journal of transplantation | | 2006 | 895 | 305 | ||
| Severe congenital hyperinsulinism caused by a mutation in the Kir6.2 subunit of the adenosine triphosphate-sensitive potassium channel impairing trafficking and function | The Journal of clinical endocrinology and metabolism | | 2005 | 724 | 451 | ||
| The zinc finger-containing transcription factor Gata-4 is expressed in the developing endocrine pancreas and activates glucagon gene expression | Molecular endocrinology | | 2005 | 622 | 0 | ||
| Pax2 mutant mice display increased number and size of islets of Langerhans but no change in insulin and glucagon content | European journal of endocrinology | | 2004 | 703 | 0 | ||
| Islet autotransplantation for the prevention of surgical diabetes after extended pancreatectomy for the resection of benign tumors of the pancreas | Transplantation proceedings | | 2004 | 812 | 0 | ||
| Islet of Langerhans allogeneic transplantation at the University of Geneva in the steroid free era in islet after kidney and simultaneous islet-kidney transplantations | Transplantation proceedings | | 2004 | 805 | 1 | ||
| Agenesis of human pancreas due to decreased half-life of insulin promoter factor 1 | The Journal of clinical endocrinology and metabolism | | 2003 | 640 | 0 | ||
| Islet autotransplantation after left pancreatectomy for non-enucleable insulinoma | American journal of transplantation | | 2003 | 863 | 702 | ||
| Insulin independence after conversion to tacrolimus and sirolimus-based immunosuppression in islet-kidney recipients | Transplantation | | 2003 | 761 | 1 | ||
| Ectopic expression of the beta-cell specific transcription factor Pdx1 inhibits glucagon gene transcription | Diabetologia | | 2003 | 704 | 226 | ||
| Molecular detection of circulating beta-cells after islet transplantation | Diabetes | | 2002 | 743 | 401 | ||
| An arginine to cysteine(252) mutation in insulin receptors from a patient with severe insulin resistance inhibits receptor internalisation but preserves signalling events | Diabetologia | | 2002 | 495 | 0 | ||
| Human islet allotransplantation with Basiliximab in type I diabetic patients with end-stage renal failure | Transplantation proceedings | | 2002 | 729 | 0 | ||
| Hepatic nuclear factor-3 (HNF-3 or Foxa2) regulates glucagon gene transcription by binding to the G1 and G2 promoter elements | Molecular endocrinology | | 2002 | 535 | 0 | ||
| Pdx1 level defines pancreatic gene expression pattern and cell lineage differentiation | The Journal of biological chemistry | | 2001 | 667 | 1,725 | ||
| Insulin independence and normalization of oral glucose tolerance test after islet cell allotransplantation | Transplant international | | 2001 | 823 | 0 | ||
| Human islet transplantation: lessons from 13 autologous and 13 allogeneic transplantations | Transplantation | | 2000 | 729 | 0 | ||
| Le traitement du diabète par transplantation: quelles sont les indications | Médecine et hygiène | | 2000 | 674 | 0 | ||
| Transplantation d'îlots de Langerhans: Quo vadis? | Médecine et hygiène | | 1998 | 676 | 0 | ||
| Results of human islet allotransplantation in cystic fibrosis and type I diabetic patients | Transplantation proceedings | | 1998 | 758 | 0 | ||
| Ablation of islet endocrine cells by targeted expression of hormone-promoter-driven toxigenes | Proceedings of the National Academy of Sciences of the United States of America | | 1994 | 636 | 1 | ||
| Air in the bones: multifocal anaerobic osteomyelitis associated with oat cell carcinoma | BMJ. British medical journal | | 1985 | 578 | 0 | ||
| Increased clearance and degradation of [3H]insulin in streptozotocin diabetic rats | The Journal of clinical investigation | | 1981 | 597 | 0 | ||
| Resistance against subcutaneous insulin successfully managed with aprotinin | Lancet | 1980 | 675 | 0 | |||
| Inhibition of degradation of insulin by ophthalamic acid and by a bovine pancreatic proteinase inhibitor | Biochemical journal | | 1979 | 645 | 0 |
